Jump to section
To make the healthcare industry more efficient, more affordable, and more human.
Under ballooning pressures, greater efficiency on the administrative side of healthcare could substantially improve the quality and speed of care. Olive, originally CrossChx, provides automated AI solutions to help fix the interoperability of various healthcare systems, and free up the human workforce by automating repetitive, high-volume tasks.
An interesting facet of its offerings is the company's expressly "human" AI bot, designed as a complementary, not competitive, addition to the workforce. Whilst the high stakes of error in the healthcare sector have slowed the development and uptake of AI tools, a refined and full-service offering such as what Olive provides gives the company an edge in this field.
In 2022, after several years of growth, Olive was forced to restructure and re-strategize, following external pressures and strategical missteps, with business focus shifting towards expanding its customer base, driving steady revenue growth, and creating value for the market and customers.
Kirsty
Company Specialist at Welcome to the Jungle
Jul 2021
$400m
LATE VC
Dec 2020
$225.5m
LATE VC
This company has top investors
Sean Lane
(CEO)A former United States Air Force Officer, NSA Intelligence Officer and founder of APX Labs, Digital Harbor Foundation and Betamore. They are also CEO of Circulo Health.